Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Cystic Fibrosis Drugs News Monitoring

Get by Email • RSS

Published on May 31, 2025

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

mNEXSPIKE becomes Moderna's third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new …

Source: Corsicana Daily Sun - Texas - Neutral
Published on May 31, 2025

Jim Cramer Notes Verona Pharma plc (VRNA) “Loses a Lot of Money”

We recently published a list of Jim Cramer Put These 14 Stocks Under the Microscope. In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against other stocks that Jim Cramer discusses. Answering a caller’s query …

Source: Yahoo Finance - Center-left
Published on May 30, 2025

Doctors work to debunk myths about cystic fibrosis

FARGO — Doctors at Essentia Health are using Cystic Fibrosis Awareness Month to clear up misconceptions about the rare genetic disorder. According to the CDC, nearly 35,000 people in the United States are living with cystic fibrosis, which can cause lung …

Source: InForum - North Dakota - Neutral
Published on May 30, 2025

Sanofi, Regeneron's IL-33 mAb Misses Primary Endpoint in Late-Stage COPD Trial

The investigational interleukin (IL)-33 inhibitor itepekimab demonstrated a statistically significant 27% reduction in moderate or severe COPD exacerbations at 52 weeks in former smokers in the AERIFY-1 phase 3 trial (n=1,127), while a second identically …

Source: Patient Care - Pending
Published on May 30, 2025

Regeneron Stock Drops On Mixed Results For Smoker’s Lung Treatment

Both trials were conducted during the COVID-19 pandemic, a factor the companies said may have influenced the outcomes. Regeneron Pharmaceuticals (REGN) shares dropped nearly 10% in premarket trading Friday after mixed results from late-stage trials of …

Source: myMotherLode - Pending
Published on May 30, 2025

Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data

Regeneron Pharmaceuticals, Inc. REGN and Sanofi SA SNY on Friday announced results from two Phase 3 trials of itepekimab in chronic obstructive pulmonary disease (COPD) patients. Phase 3 AERIFY-1 trial evaluating itepekimab in adults who were former …

Source: Benzinga - Neutral
Published on May 29, 2025

Connected Drug Delivery Devices: Emerging Market Trends

By Pooja Sharma, Global Market Insights The global healthcare landscape is undergoing a dramatic shift with the increasing adoption of connected drug delivery devices. These smart solutions integrate digital connectivity — often via Bluetooth — with …

Source: Drug Delivery Leader - Pending
Published on May 27, 2025

Campbell River walks to make Cystic Fibrosis history

Around100 people walked, ran or rode bikes to help raise funds for Cystic Fibrosis Canada on May 25 Around100 people walked, ran or rode bikes to help raise funds for Cystic Fibrosis Canada on May 25. Over $20,000 was raised in Campbell River, adding to …

Source: Campbell River Mirror - Pending
Published on May 29, 2025

Yeast cells brew human DNase1 for first time, paving way for cheaper treatment

DNase1 is a powerful human enzyme that breaks down free DNA in the body. It plays a critical role in clearing thick mucus in cystic fibrosis patients. For decades, scientists have relied on expensive production methods using immortalized hamster cells. But …

Source: Interesting Engineering - New York - Neutral
Published on May 29, 2025

The drug that could change Caitlin's life costs $250,000

After years of struggling to catch a full breath, Caitlin Magagna was overjoyed when a potentially life-changing drug was approved for Australians like her. Magagna, 25, was diagnosed with cystic fibrosis as a newborn and carries two rare gene mutations …

Source: Nine - Neutral
Published on May 28, 2025

Pharmacist Perspectives on ADC-Associated Toxicity in NSCLC Treatment

As antibody-drug conjugates (ADCs) become increasingly integrated into the treatment landscape for non–small cell lung cancer (NSCLC), understanding how to predict, prevent, and manage associated toxicities has become critical to optimizing patient care. …

Source: Pharmacy Times - Neutral
Published on May 28, 2025

Olympus secures FDA clearance for most advanced imaging endoscopes

UPPER SAUCON TWP., Pa. - Olympus Corporation of the Americas has secured a stamp of approval from the Food and Drug Administration (FDA) for what it calls its most advanced imaging endoscopes. Olympus, which has called Upper Saucon Township home since 2006 …

Source: WFMZ - Pennsylvania - Neutral
Published on May 31, 2025

Sanofi & Regeneron announce itepekimab meet the primary endpoint in one of two COPD phase 3 studies

The AERIFY-1 phase 3 study evaluating itepekimab in former smokers with inadequately controlled chronic obstructive pulmonary disease (COPD) met the primary endpoint of a statistically significant reduction in moderate or severe acute exacerbations …

Source: Pharmabiz.com - Neutral
Published on May 28, 2025

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

The three major indexes slid in March and April as investors worried about the impact of President Donald Trump's import tariffs on the economy -- but in recent weeks, optimism about lower, more manageable tariff levels has grown. Trump struck a deal …

Source: The Motley Fool USA - Neutral
Published on May 27, 2025

Olympus Announces FDA Clearance of Its Most Advanced Imaging Endoscopes

EDOF™ Technology Provides a Continuously Sharp Image with Minimal Focal Adjustment as Part of the EVIS X1™ Endoscopy System CENTER VALLEY, Pa., May 27, 2025 /PRNewswire/ -- Olympus, a global medical technology company committed to making people…

Source: WFMZ - Pennsylvania - Neutral
Published on May 30, 2025

Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials

AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically meaningful benefit AERIFY-2, a second Phase 3 trial, did …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025

Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies

Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 29, 2025

HCPLive Five - Pulmonology Updates at ATS International Conference 2025

With many different clinicians, researchers, and industry leaders convening in San Francisco, the American Thoracic Society (ATS) 2025 International Conference once again solidified its status as a cornerstone event in the field of pulmonology. The annual …

Source: HCPLive - Pending
Published on May 30, 2025

Pipes: Some lawmakers want to ban the next cancer breakthrough

Lawmakers in Iowa, Idaho, Texas and Kentucky have introduced bills that would ban or restrict vaccines that use messenger RNA, or mRNA, technology — despite its immense potential for treating and even preventing some of the most vexing diseases known to …

Source: Longview News-Journal - Texas - Pending

Got News to Share? Send 2 FREE Releases ↓

Featured Releases

Got News to Share? · Submit · See All

Published on May 31, 2025 - 11:07 GMT

URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued for Securities Fraud after Stock Plummets 45% – Contact BFA ...

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company’s senior executives for potential violations …

Distribution channels: Consumer Goods, Law ...
Published on May 30, 2025 - 12:48 GMT

Nasal Polyposis Drugs Market Size, Trends & Top Treatment Options 2025 | DataM Intelligence

The Global Nasal Polyposis Drugs Market is estimated to reach at a CAGR of 6.6% during the forecast period 2024-2031. AUSTIN, TX, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Market Overview: The Global Nasal Polyposis Drugs Market is expanding …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 30, 2025 - 12:45 GMT

IgA Nephropathy Drugs Market to Grow at 18.1% CAGR Driven by Biologic Innovations and FDA Approvals| DataM Intelligence

The IgA Nephropathy drugs market is set for 18.1% CAGR growth, led by biologics, FDA approvals, and major pharma R&D efforts worldwide. NEW YORK, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Market Overview: The IgA Nephropathy …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 12:30 GMT

Prescription Drugs Market to Reach USD 2.15 Trillion by 2031, Driven by Innovation and Demand | DataM Intelligence

Prescription drug market expands rapidly due to AI in pharma, rising diseases, and global access to advanced therapies. AUSTIN, TX, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- The global prescription drugs market is experiencing robust …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 30, 2025 - 23:35 GMT

Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Jack Burnett ("CEO") today announced that he has filed an early warning report (the "Early Warning Report") under National Instrument 62-103 – The Early Warning System and Related Take-Over Bid …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 28, 2025 - 18:00 GMT

BestRx Pharmacy Software Announces Integration with Lansworth Pharma SelfServe’s Pharmaself24 Kiosk Solution

BestRx is pleased to announce a new integration with Lansworth Pharma SelfServe, an advanced automated prescription pickup solution. OAKBROOK, IL, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- BestRx, a RedSail Technologies company and a leading …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 20:01 GMT

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 19:44 GMT

URGN Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against UroGen Pharma Ltd.

SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025. …

Distribution channels: Consumer Goods, Law ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 817,936,333 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 31, 2025 - 15:15 GMT

San Francisco Dental Implant Center Announces New Content on Convenient Dental Implant Locations in SF

San Francisco Dental Implant Center, a top dental implant center in San Francisco, California, is proud to announce new content focusing on convenient location. SAN FRANCISCO, CA, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- San Francisco …

Distribution channels: Building & Construction Industry, Consumer Goods ...
Published on May 31, 2025 - 12:04 GMT

Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell ...

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 31, 2025 - 12:00 GMT

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 31, 2025 - 00:00 GMT

The Good Feet Store Opens in Seabrook, NH to Help Local Residents and Workforce Live the Life They Love

The Leading Retailer of Premium, Personally-Fitted Arch Supports Expands with the Tenth Store in the Boston Area SEABROOK, NH, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- The Good Feet Store, recognized nationally as the market-leading …

Distribution channels: Companies, Consumer Goods ...
Published on May 31, 2025 - 00:00 GMT

Nurses for Natural Health Hosts Transformative Yoga Retreat for Nurses in France

PHOENIX , AZ, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- This July, Nurses for Natural Health invites nurses from around the world to join a one-of-a-kind restorative yoga retreat in the picturesque town of Luz-Saint-Sauveur. Designed to …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in ...

Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic adenocarcinoma1 Post-hoc analysis of NAPOLI 3 study determined characteristics associated with long-term survival, with median …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec ...

L’essai de Phase III NAPOLI 3 est la plus grande étude interventionnelle réalisée à ce jour avec la plus longue période de suivi des patients avec un adénocarcinome pancréatique métastatique1. L’analyse post-hoc de l’étude NAPOLI 3 a permis de déterminer …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 31, 2025 - 12:00 GMT

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with ...

26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases Deep and durable responses ongoing for up to 37 weeks through the data cutoff, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 30, 2025 - 22:30 GMT

From protocol to empathetic accompaniment: improving dialysis care via psychological education

A groundbreaking shift is happening in the treatment of chronic kidney disease thanks to the work of psychologist Mrs. Erika Danitza Rocabado Vargas. RICHMOND, VA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- With over 19 years of clinical …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 30, 2025 - 21:46 GMT

NYC Optician French Optical Fashion, Inc. Educates on Eye Wellness

French Optical Fashion, Inc. launches NYC optician campaign to promote eye health with exams and education. NEW YORK, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- French Optical Fashion, Inc., a premier NYC optician located at 7 East …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 21:45 GMT

BREAST CANCER ALLIANCE AWARDS $1.3M IN GRANTS TO ADVANCE RESEARCH, BREAST SURGICAL ONCOLOGY TRAINING, AND ACCESS TO CARE

GREENWICH, CT, CT, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Breast Cancer Alliance (BCA), one of the nation’s leading and most impactful nonprofit breast cancer organizations, proudly announces the awarding of $1.3 million in 2025 grants …

Distribution channels: Beauty & Hair Care, Education ...
Published on May 30, 2025 - 21:17 GMT

New Book Reveals the Overlooked Toxins Impacting American Homes

A shocking exposé reveals how everyday home materials harm your family—and the proven steps to detox, protect, and rebuild your health. ORLANDO, FL, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- What if the place you trust the most is …

Distribution channels: Agriculture, Farming & Forestry Industry, Book Publishing Industry ...
Published on May 30, 2025 - 20:39 GMT

Meaningful Life Counseling Pioneers Early Couples Therapy in CT for Lasting Love

Meaningful Life Counseling in CT promotes early couples therapy to strengthen relationships, offering free consultations to help partners thrive. WOODBRIDGE, CT, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- As couples face mounting …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 20:00 GMT

Mobility City Holdings Inc Celebrates Six Years of Serving People in Lake County Illinois & Surrounding Communities

Kevin Pignone opened his showroom in Grayslake IL with a mission to help people with mobility challenges via the repair, rental and sale of mobility equipment BOCA RATON, FL, US, May 30, 2025 /⁨EINPresswire.com⁩/ -- Mobility City Holdings, Inc., …

Distribution channels: Business & Economy, Companies ...
Published on May 30, 2025 - 19:45 GMT

Free Training Event During CPR and AED Awareness Week Aims to Equip More People to Act in Emergencies

Hands-on virtual session June 6 empowers participants with the skills and confidence to respond in cardiac emergencies—no experience required. HOUSTON, TX, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- In an effort to empower more …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 30, 2025 - 19:15 GMT

LosAngelesMedicalMalpracticeLawyers.com Launches to Connect Individuals with Malpractice Lawyers

LOS ANGELES, CA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- A new website, losangelesmedicalmalpracticelawyers.com, has been launched to assist individuals in the Los Angeles area in finding the best medical malpractice lawyer for their …

Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
Published on May 30, 2025 - 19:00 GMT

A New Initiative for the Wellness of Children and Communities: A Mental Health Awareness Event with U.S. - Japan Experts

～Heartfulness × Hip-Hop Therapy × Expressive Arts Therapy ～“M.O.F.U.” to Be Held for the First Time in Katsushika, Tokyo TOKYO, CA, JAPAN, May 30, 2025 /⁨EINPresswire.com⁩/ -- On Saturday, June 7, 2025, a mental health awareness event titled“M.O.F …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 30, 2025 - 18:40 GMT

Media Statement By Dr. Gail C. Christopher: America 5 Years After George Floyd’s Murder

Dr. Christopher, leader of the National Collaborative for Health Equity, says racial justice faces headwinds, but accomplishments have not been erased WASHINGTON, DC, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Five years ago, at the …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 30, 2025 - 18:28 GMT

Cosmetic Dentistry Experts Drs. John and Jade Moreau of Unforgettable Smiles Talk How Enhanced Smiles Build Confidence

ALEXANDRIA, LA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Drs. John and Jade Moreau of Unforgettable Smiles is featured in the latest edition of HelloNation, where he shares valuable insight on the role of cosmetic dentistry in improving both …

Distribution channels: Beauty & Hair Care, Business & Economy ...